Efficacy of esketamine nasal spray plus oral antidepressant treatment for relapse prevention in patients with treatment-resistant depression: A randomized clinical trial - MD Linx

Submitted by Anonymous (not verified) on Wed, 09/11/2019 - 11:14

Efficacy of esketamine nasal spray plus oral antidepressant treatment for relapse prevention in patients with treatment-resistant depression: A randomized clinical trial  MD LinxGiven a short-term efficacy of esketamine for treatment-resistant depression (TRD), researchers here focussed on the long-term effects of esketamine nasal ...